MRI Contrast Agent Market is Anticipated to Increase at a Stable CAGR over the Forecast Period (2023 to 2029)

MRI contrast agent market is anticipated to grow at a considerable CAGR of 4.2% during the forecast period. The rising frequency of chronic diseases affecting the brain, spine, and liver, as well as the occurrence of joint injuries in developing nations, however, the cost of MRI diagnostic is prohibitive, limiting the use of MRI techniques for diagnosis. As a result, the market's expansion may be slowed. The cost of MRI contrast agents is reasonable, however, the cost of an MRI scan is relatively high. Patients and clinicians alike are hesitant to use MRI for disease diagnosis as a result of this. For instance, In November 2020, Siemens Healthineers has presented a new class of magnetic resonance imaging (MRI) systems that the company named "High-V MRI." The scanner's unique combination of digital technologies and the new field strength of 0.55 tesla broadens the range of clinical applications for MRI systems. Magnetom Free. Max considerably improves pulmonary imaging with MRI and allows patients with implants to be scanned much more accurately. Siemens Healthineers has also enlarged the bore size to 80 cm, making the experience more comfortable for patients.

To Request a Sample of our Report on MRI Contrast Agent Market: https://www.omrglobal.com/request-sample/mri-contrast-media-market

Market Coverage

· The market number available for - 2022-2030

· Base year- 2022

· Forecast period- 2023-2030

Segment Covered-

· By Product Type

· By Indication

Regions Covered-

· North America

· Europe

· Asia-Pacific

· Rest of the World

Competitive Landscape- including Bayer AG, Bracco Imaging S.p.A, GE Healthcare, iMax Diagnostic Imaging Ltd., Nano Therapeutics Pvt. Ltd. and others.

A full Report of MRI Contrast Agent Market is Available @ https://www.omrglobal.com/industry-reports/mri-contrast-media-market

MRI Contrast Agent Market Segmentation

By Product Type

· Iodinated

· Gadolinium

· Barium

· Microbubble

By Indication

· Cardiovascular

· Neurological

· Oncology

· Gastrointestinal

· Others

Regional Analysis

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

Company Profiles

· Acro Lifesciences Pvt. Ltd.

· Beijing Beilu Pharmaceutical Co., Ltd.

· Guerbet

· J. B. Chemicals and Pharmaceuticals Ltd.

· Jodas Expoim

· Kiran X-ray Pvt. Ltd.

· Lantheus Medical Imaging, Inc.

· Livealth Biopharma Pvt. Ltd.

· Rege Imaging & Cine Film Pvt. Ltd.

· SANOCHEMIA Pharamazeutica GmbH

· Subhra Pharma Pvt. Ltd.

· Trivitron Healthcare Pvt. Ltd.

· Unijules Life Sciences Ltd.

· Unispire Biopharma Pvt. Ltd.

Reasons to buy from us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/mri-contrast-media-market

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.